StockWatch
·
Pharmaceuticals
Quarterly Result26 May 2026, 12:51 pm

Makers Labs FY26: Revenue from Operations at ₹5,034.73 Lacs

AI Summary

Makers Laboratories Ltd. announced its standalone and consolidated financial results for the fiscal year 2025-26. The Board of Directors approved the audited financial results in a meeting held on May 26, 2026. Standalone revenue from operations for FY26 stood at ₹5,034.73 Lacs. The audit reports for both standalone and consolidated financial results have an unmodified opinion. The company's primary operating segment is Pharmaceuticals.

Key Highlights

  • Standalone revenue from operations for FY26 reached ₹5,034.73 Lacs.
  • The Board approved audited standalone and consolidated results on May 26, 2026.
  • Auditors issued an unmodified opinion on the standalone and consolidated financial results.
  • Basic & Diluted Earnings per share (of ₹10/- each) stood at ₹7.87.